Chau Cheng | Vice President of Investor Relations & Corporate Communications |
Sean McCarthy | Chief Executive Officer & Chairman |
Carlos Campoy | Chief Financial Officer |
Kaveri Pohlman | BTIG |
Etzer Darout | BMO Capital Markets |
Supawat Thongthip | Mizuho |
Mitchell Kapoor | H.C. Wainwright |
Good afternoon, everyone. Thank you for standing by. Welcome to the CytomX Therapeutics Second Quarter 2022 Financial Results Call. Please be advised that today's call is being recorded. I would now like to hand the call over to your host for today Chau Cheng, CytomX's Vice President, Investor Relations and Corporate Communications.